|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 4.840 USD | +2.98% |
|
-8.68% | -4.33% |
| 10/09 | SCYNEXIS, Inc. Announces Executive Changes, Effective September 9, 2026 | CI |
| 10/09 | SCYNEXIS, Inc. Announces CFO Changes, Effective September 9, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCYNEXIS, INC. | Other Pharmaceuticals | +2.98% | -8.68% | -4.33% | -45.98% | -90.29% | 4.82Cr |  |  | |
- Stock Market
- Stocks
- SCYX Stock
- Charts SCYNEXIS, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
